CDK4/6-IN-12
CDK4/6-IN-12 is a potent cyclin-dependent kinase 4/6 (CDK4/6) inhibitor. CDK4/6-IN-12 has enzymatic inhibitory activity for CDK4 and CDK6 with IC50 of 592.3 nM and 3090 nM, respectively. CDK4/6-IN-12 can be used for the research of cancer[1].
Product Specifications
CAS Number
[2445205-24-1]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk4-6-in-12.html
Purity
99.76
Solubility
10 mM in DMSO
Smiles
CC1=CN2C3=NC(N)=NC=C3C(C)=C(C2=N1)C#N
Molecular Formula
C12H10N6
Molecular Weight
238.25
References & Citations
[1]Chen Shi, et al. Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors. Eur J Med Chem. 2020 May 1;193:112239.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK4; CDK6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS9424311-01 0.02 mg
Recombinant Toxocara canis 26 kDa secreted antigen (TES-26), partial
Ask
View Details MBS9424311-02 0.1 mg
Recombinant Toxocara canis 26 kDa secreted antigen (TES-26), partial
Ask
View Details 
MBS9424311-03 1 mg
Recombinant Toxocara canis 26 kDa secreted antigen (TES-26), partial
Ask
View Details MBS9424311-04 5x 1 mg
Recombinant Toxocara canis 26 kDa secreted antigen (TES-26), partial
Ask
View Details